All Online

13 - 22 of 22 results

Refine

Active filters

Neurology
Tile overview image
0.25 CME CREDIT

This short podcast will focus on new and emerging monoclonal antibody therapies targeting β-amyloid, with a focus on the importance of early recognition and diagnosis of Alzheimer disease to allow prompt treatment for patients in the early stages of the disease who may derive the most benefit from these agents.


Frankly Speaking CME 259
0.25 CME CREDIT

Per CDC data, approximately 2.5 million Americans present each year to emergency departments with head injuries, and 15% of all high school students report experiencing at least one concussion. Current guidelines recommend physical and cognitive rest for 24-48 hours post-concussion with minimal guidance on screen time parameters. Recent evidence is emerging that supports avoidance of screen time and encouragement of aerobic activity as strategies to shorten and lessen post-concussion symptoms. Join us as we discuss 2 recent studies regarding screen-time and aerobic exercise that add critical information to best practice for reducing post-concussion symptoms.


Frankly Speaking CME 258
0.25 CME CREDIT

A Brainy Approach to Treating Chronic Low Back Pain - Frankly Speaking EP 258

Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

Chronic pain affects 20% of people in the United States, and chronic low back pain is the most common cause of chronic pain. Although some treatments can reduce the severity of the pain, the persistence of chronic low back pain is a source of frustration for both patients and clinicians. Join us to discuss how behavioral and psychological therapy should be part of the treatment for chronic low back pain and how new approaches may be much more effective than existing therapies.


Frankly Speaking CME 247
0.25 CME CREDIT

A Fishy Method to Prevent Migraines - Frankly Speaking EP 247

Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

When it comes to chronic migraines, your first-line prevention is probably medication, but according to a new study, it may not have to be. Certain foods may play a role in increasing and decreasing migraine recurrence. Join us to review a recent randomized controlled trial aimed at preventing migraines in those with chronic migraines.


Elderly man with physician
0.29 CME CREDIT

Alzheimer disease (AD) is a growing concern as the population ages. Primary care clinicians are often the first to screen for and identify signs of cognitive impairment which may be due to AD. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions and provides helpful tips for assessing cognitive impairment in primary care and provides insight into the current and emerging role of neuroimaging and biomarkers in the diagnosis of AD. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.


Women with migraine consulting with doctor
0.36 CME CREDIT

Your Questions About Migraine Work-Up And Prevention Answered

0.25 CME/MOC
0.36 AANP | 0.12 Pharmacology

In this podcast, Drs. Dawn Buse and Michael Ready will address questions about migraine diagnosis and treatment posed by Pri-Med learners during recent programs. Topics will include red flags requiring evaluation for serious secondary causes of headache, tips on encouraging patients to use headache diaries, the role of supplements in migraine prevention, and more!


Young women sitting and holding her head
0.28 CME CREDIT

Proving Cassandra Wrong: The Case For Migraine Prevention

0.25 CME/MOC
0.28 AANP | 0.19 Pharmacology

This podcast will focus on the case of a patient with migraine attacks that have been increasing in frequency and the disability they cause. Faculty will discuss when to initiate preventive migraine treatment and consider medication options for this patient that will take into account her comorbid conditions and potential issues with adherence.


Elderly patient holding doctors hands
0.25 CME CREDIT

Alzheimer disease (AD) treatment is evolving. With this rapid expansion in potential therapies, there remain challenges and misconceptions. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions about new and emerging disease-modifying therapies and explores ways in which these treatments may be considered in the future for patients. The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: Early Recognition and Emerging Therapy.


Tile overview image
1 CME CREDIT

Common Urgent Care Cases and Navigating Pitfalls for PCPs

1.00 CME/MOC
1.00 AANP | 0.25 Pharmacology

Join expert faculty as they discusses four common urgent care presentations for primary care clinicians. Faculty will also review pertinent positives and negatives associated with potential red flags to avoid malpractice, all without over testing or slowing throughput.


jeopardy game logo with primed logo underneath
0.25 CME CREDIT

Despite the fact that nearly 40 million Americans suffer from migraines, management remains suboptimal, even in patients who seek treatment because of multiple and overlapping causes that include underuse and inappropriate use of available abortive and preventive therapies, insufficient treatment efficacy of older therapies, contraindications to existing agents, tolerability issues with older therapies, and poor adherence. Monoclonal antibodies specifically targeting the CGRP ligand or receptor, as well as a CGRP-targeted gepant, provide mechanism-specific options for migraine prevention, with proven efficacy and tolerability. This activity will discuss newly available agents for migraine prevention.